Alivus Life Sciences Limited (BOM:543322)
India · Delayed Price · Currency is INR 974.20
-5.85 (-0.60%)
At close: Mar 30, 2026
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 119.39 billion as of March 31, 2026. Its market cap has decreased by -9.70% in one year.
Market Cap
119.39B
Enterprise Value
113.46B
Revenue
25.12B
Ranking
n/a
PE Ratio
21.96
Stock Price
974.20
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 119.39B, an increase of 30.18%. That is a compound annual growth rate of 5.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 119.39B | 6.17% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 154.88B |
| Shilpa Medicare | 68.44B |
| Suven Life Sciences | 34.28B |
| Gujarat Themis Biosyn | 27.41B |
| IOL Chemicals and Pharmaceuticals | 22.87B |
| NGL Fine-Chem | 13.11B |
| Bajaj HealthCare | 9.50B |
| Anlon Healthcare | 6.16B |